Name
OÜ PEREARST TARVO KIUDMA
Registry code
10911636
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
09.12.2002 (21)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
86211 - Provision of general medical treatment
456 818 €
32 895 €
7%
3 725 €
(estimate is approximate)
46 582 €
3
Submitted
No tax arrears
71%
30%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Tarvo Kiudma 07.06.1966 (58) | 100% - 2 556.00 EUR | Board member | Direct ownership | Founder |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Osaühing BFG 10724087 | 16% - 25 000.00 EEK | - | - |
| 2019 13.04.2020 | 2020 13.05.2021 | 2021 24.02.2022 | 2022 26.06.2023 | 2023 12.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 259 815 € | 289 755 € | 358 253 € | 390 500 € | 456 818 € |
| Net profit (loss) for the period | 36 788 € | 30 782 € | 49 343 € | 27 021 € | 32 895 € |
| Profit Margin | 14% | 11% | 14% | 7% | 7% |
| Current Assets | 24 262 € | 27 720 € | 46 553 € | 34 090 € | 33 399 € |
| Fixed Assets | 59 613 € | 67 564 € | 70 430 € | 84 382 € | 75 657 € |
| Total Assets | 83 875 € | 95 284 € | 116 983 € | 118 472 € | 109 056 € |
| Current Liabilities | 37 334 € | 47 961 € | 50 317 € | 63 127 € | 62 474 € |
| Non Current Liabilities | 0 € | - | - | 1 658 € | 0 € |
| Total Liabilities | - | - | - | 64 785 € | - |
| Share Capital | - | - | - | - | - |
| Equity | 46 541 € | 47 323 € | 66 666 € | 53 687 € | 46 582 € |
| Employees | 3 | 3 | 4 | 3 | 3 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 22 256.86 € | 21 739.74 € | 3 |
| 2023 Q4 | - | 24 535.18 € | 21 550.47 € | 3 |
| 2023 Q3 | - | 21 812.48 € | 22 907.19 € | 3 |
| 2023 Q2 | - | 24 428.82 € | 23 389.76 € | 4 |
| 2023 Q1 | - | 20 955.8 € | 21 965.65 € | 4 |
| 2022 Q4 | - | 22 609.51 € | 19 049.82 € | 4 |
| 2022 Q3 | - | 14 156.73 € | 14 679.3 € | 3 |
| 2022 Q2 | - | 20 365.46 € | 18 638.64 € | 3 |
| 2022 Q1 | - | 25 926.32 € | 27 270.28 € | 3 |
| 2021 Q4 | - | 16 180.05 € | 14 139.28 € | 4 |
| 2021 Q3 | - | 20 753.45 € | 17 382.04 € | 3 |
| 2021 Q2 | - | 14 524.34 € | 15 054.62 € | 3 |
| 2021 Q1 | - | 15 337.81 € | 14 987.36 € | 4 |
| 2020 Q4 | - | 11 841.47 € | 12 192.92 € | 4 |
| 2020 Q3 | - | 15 905.85 € | 14 304.31 € | 4 |
| 2020 Q2 | - | 14 531.34 € | 14 161.88 € | 4 |
| 2020 Q1 | - | 17 169.65 € | 17 931.25 € | 4 |
